Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Arthritis, Rheumatoid × Leflunomide × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Glioma 2 Central Nervous System Neoplasms 2 Brain Neoplasms 2 Triple Negative Breast Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Myasthenia Gravis 1 Gliosarcoma 1 Glioblastoma 1 Breast Neoplasms 1 Breast Diseases 1 Astrocytoma 1 Arthritis, Rheumatoid 1

Interventions

Adalimumab 10 Etanercept 8 Methotrexate 6 tocilizumab 5 golimumab 5 Rituximab 5 Abatacept 5 tofacitinib 4 Certolizumab Pegol 4 olokizumab 3 Infliximab 3 Tumor Necrosis Factor Inhibitors 2 Saline Solution 2 Antirheumatic Agents 2 upadacitinib 1 secukinumab 1 sarilumab 1 mavrilimumab 1 baricitinib 1 Vitamin D 1 Vaccines 1 Syringes 1 Sulfasalazine 1 Radioimmunodetection 1 RC-18 1 Pharmaceutical Preparations 1 Lysine Acetyltransferase 5 1 Leflunomide 1 ISIS104838 1 Hydroxychloroquine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03449758 2022-04-28

SariPRO

Sanofi

Phase 4 Completed

84 enrolled 36 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡